4th Quarter - Report

EMD SERONO, INC. for EMD SERONO INC

Firm
Client
Income
—
Expenses
$490,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

13 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

H.R. 133: Consolidated Appropriations Act, 2021; provisions related to funding for COVID-19 vaccine and testing

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA)

Bills named: H.R. 133 (116th)

Trade (domestic/foreign) TRD

General discussions related to Sec. 301 Tariffs

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA)

Science/Technology SCI

H.R. 7178: Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act; provisions related to semiconductor manufacturing S.3933: Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act; provisions related to semiconductor manufacturing

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS)

Bills named: S. 3933 (116th), H.R. 7178 (116th)

Defense DEF

S. 4049: National Defense Authorization Act for Fiscal Year 2021; provisions related to the Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act portions of bill

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); SENATE

Bills named: S. 4049 (116th)

Chemicals/Chemical Industry CHM

General discussions related to the Toxic Substances Control Act; provisions related to Section 5/Pre-Manufacture Notice (PMN) General discussions related to National raw materials stockpile for future vaccine preparedness

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

H.R. 133: Consolidated Appropriations Act, 2021; provisions related to funding for closing the "Homework Gap"

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —

Contacted: Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Bills named: H.R. 133 (116th)

Taxation/Internal Revenue Code TAX

H.R. 6930: Manufacturing API, Drugs, and Excipients (MADE) in America Act of 2020; issues related to tax incentives for reshoring of U.S. supply chains H.R. 7178: Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act; issues related to tax incentives for reshoring of U.S. supply chains S.3933: Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act;issues related to tax incentives for reshoring of U.S. supply chains S.3945: Bring Entrepreneurial Advancements To Consumers Here In North America Act; issues related to tax incentives for reshoring of supply chains (semiconductors and pharmaceuticals) General discussions related to the implementation of the Tax Cut and Jobs Act of 2017 (P.L. 116-97)

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —
DANIEL M. HARDER —
MALLORI ANNE MERANDINO —
WENDY SUSSMAN —

Contacted: Executive Office of the President (EOP); Environmental Protection Agency (EPA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 7178 (116th), S. 3933 (116th), H.R. 6930 (116th), S. 3945 (116th)

Copyright/Patent/Trademark CPT

General discussions regarding biopharmaceutical innovation and patent policy issues

LobbyistCovered position, as disclosed
DANIEL M. HARDER —
MALLORI ANNE MERANDINO —
WENDY SUSSMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Economics/Economic Development ECN

General discussion of issues related to caregiving and the Healthy Women, Healthy Economies initiative

LobbyistCovered position, as disclosed
DANIEL M. HARDER —
MALLORI ANNE MERANDINO —
WENDY SUSSMAN —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Health Issues HCR

H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act: issues related to drug pricing Centers for Medicare & Medicaid Services (CMS-5528-ANPRM)-Advance Notice of Proposed Rulemaking (ANPRM)-Medicare Program; International Price Index Model for Medicare Part B drugs 2021 Notice of Benefit and Payment Parameters Proposed Rule - 340B Drug Pricing Program policy issues (Draft) 21st Century Cures Act 2.0; all healthcare provisions of the draft General discussions regarding support for, and importance of, care-giving General healthcare issues surrounding the COVID-19 pandemic General issues surrounding healthcare supply chain General discussions regarding drug cost and pricing policy issues General discussions regarding Most Favored Nations/International Price Index Model for Medicare Part D drugs

LobbyistCovered position, as disclosed
DANIEL M. HARDER —
MALLORI ANNE MERANDINO —
WENDY SUSSMAN —

Contacted: SENATE; Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 6800 (116th), H.R. 3 (116th)

Medicare/Medicaid MMM

H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act: issues related to drug pricing 2021 Notice of Benefit and Payment Parameters Proposed Rule General healthcare issues surrounding the COVID-19 pandemic

LobbyistCovered position, as disclosed
DANIEL M. HARDER —
MALLORI ANNE MERANDINO —
WENDY SUSSMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Executive Office of the President (EOP)

Bills named: H.R. 6800 (116th), H.R. 3 (116th)

Government Issues GOV

H.R.1: For the People Act of 2019; provisions related to the Foreign Agents Registration Act

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —

Contacted: SENATE; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (116th)

Pharmacy PHA

H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act: issues related to drug pricing 2021 Notice of Benefit and Payment Parameters Proposed Rule General healthcare issues surrounding the COVID-19 pandemic General issues surrounding healthcare supply chain

LobbyistCovered position, as disclosed
DANIEL M. HARDER —
MALLORI ANNE MERANDINO —
WENDY SUSSMAN —

Contacted: Environmental Protection Agency (EPA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (116th), H.R. 6800 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.